UCLA Molecular Biology Institute (MBI)

United States of America (USA)

1 May 2019 - 30 April 2020

Principal institution: UCLA Division of Life Sciences

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for UCLA Molecular Biology Institute (MBI) published between 1 May 2019 - 30 April 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
41 6.06

Outputs by subject (Share)

Subject Count Share
Chemistry 5 0.43
Life Sciences 40 6.05
1 0.01
1 0.05
1 0.02
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer.
2019-08-27
0.02
1 0.12
1 1
1 0.50
3 0.70
1 0.20
3 0.18
1 0.02
1 0.04
1 0.08
6 0.79
1 0.14
1 0.07
2 0.59
1 0.43
8 0.69
1 0.11
1 0.02
1 0.08
2 0.22
Physical Sciences 4 0.41

Return to institution outputs